Lipton NJ, Lipton JH. Making the case for the case report - informing physicians of intracranial hypertension as an adverse event in tyrosine kinase inhibitor treated chronic myeloid leukemia patients. Leuk Lymphoma 2022 Mar 25:1-2. doi: 10.1080/10428194.2022.2056180.
PMID: 35337248